The Pharmacology of CD38/NADase: An Emerging Target in Cancer and Diseases of Aging.

about

Designing Blood-Brain Barrier Models Reproducing Alterations in Brain Aging Perspectives for the Development of CD38-Specific Heavy Chain Antibodies as Therapeutics for Multiple Myeloma

P2860

Q58798995-C597B457-3F9A-421F-A5B4-92D06BCEA9FC Q59128091-C6F3E791-B8E7-4F98-A07D-E9C9700A1049

P2860

The Pharmacology of CD38/NADase: An Emerging Target in Cancer and Diseases of Aging.

Item

http://www.wikidata.org/entity/Q51767119

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

The Pharmacology of CD38/NADase: An Emerging Target in Cancer and Diseases of Aging.

@en

The Pharmacology of CD38/NADase: An Emerging Target in Cancer and Diseases of Aging.

@nl

type

Item

label

The Pharmacology of CD38/NADase: An Emerging Target in Cancer and Diseases of Aging.

@en

The Pharmacology of CD38/NADase: An Emerging Target in Cancer and Diseases of Aging.

@nl

prefLabel

The Pharmacology of CD38/NADase: An Emerging Target in Cancer and Diseases of Aging.

@en

The Pharmacology of CD38/NADase: An Emerging Target in Cancer and Diseases of Aging.

@nl

P1476

The Pharmacology of CD38/NADase: An Emerging Target in Cancer and Diseases of Aging.

@en

P2093

Claudia C S Chini

http://www.w3.org/2001/XMLSchema#string

Eduardo N Chini

http://www.w3.org/2001/XMLSchema#string

Guilherme C de Oliveira

http://www.w3.org/2001/XMLSchema#string

Jair Machado Espindola Netto

http://www.w3.org/2001/XMLSchema#string

Wim van Schooten

http://www.w3.org/2001/XMLSchema#string

P2860

SIRT2 induces the checkpoint kinase BubR1 to increase lifespan

Inhibition of de novo NAD(+) synthesis by oncogenic URI causes liver tumorigenesis through DNA damage

Mutations in NMNAT1 cause Leber congenital amaurosis and identify a new disease pathway for retinal degeneration

NAD⁺-Metabolizing Ectoenzymes in Remodeling Tumor-Host Interactions: The Human Myeloma Model

Activation of SIRT3 by the NAD⁺ precursor nicotinamide riboside protects from noise-induced hearing loss

A high-fat diet and NAD(+) activate Sirt1 to rescue premature aging in cockayne syndrome

Structural Basis for Enzymatic Evolution from a Dedicated ADP-ribosyl Cyclase to a Multifunctional NAD Hydrolase

Catalysis-based inhibitors of the calcium signaling function of CD38

SAR650984, a novel humanized CD38-targeting antibody, demonstrates potent antitumor activity in models of multiple myeloma and other CD38+ hematologic malignancies

Discovery of 4-Amino-8-quinoline Carboxamides as Novel, Submicromolar Inhibitors of NAD-Hydrolyzing Enzyme CD38

P304

424-436

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.TIPS.2018.02.001

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29482842

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

P932

5885288

http://www.w3.org/2001/XMLSchema#string

The Pharmacology of CD38/NADase: An Emerging Target in Cancer and Diseases of Aging.

about

P2860

P2860

The Pharmacology of CD38/NADase: An Emerging Target in Cancer and Diseases of Aging.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932